Changing Faces: Agency, consultancy, and investor, February ...
February was a light month for agency and consultancy news, but a few interesting changes came through.
Hernexeos and what’s next, with Vicky Brown
At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
The problem of clinical non-adherence
Greater adherence to evidence-based prescribing guidelines for beta blockers represents a clear opportunity to improve patient outcomes.
After setback, Rhythm gets good news on Imcivree from FDA
Rhythm Pharma has secured the first approval in the US for a drug to treat hypothalamic obesity.
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
6th mRNA‑Based Therapeutics Summit
Advancing mRNA's Therapeutic Potential to Combat All Diseases
Agentic AI is Ready. Most Pharma Organizations Are Not
Axtria Ignite 2026 returns June 10–11 in Princeton, New Jersey
The Industry’s Most Comprehensive End-to-End TCE Forum
The 8th T Cell Engager Therapeutics Summit is taking place June 23–25 in San Diego, CA,
The Evolution Summit Announces May 2026 Program for Clinical...
marcus evans announces The Evolution Summit, taking place May 7-8, 2026 at The Ritz-Carlton, Fort Lauderdale, Florida.
PHARMAP 2026: Where Pharma Meets Policy
The Pharmaceutical Manufacturing and Packaging Congress (PHARMAP 2026)